We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Bartosiak: Trading Petmed Express's (PETS) Earnings with Options
Read MoreHide Full Article
On Monday, October 23rd, Petmed Express (PETS - Free Report) will release its second quarter earnings before the bell. The company is a Zacks Rank 1 (Strong Buy), and have a Value, Growth, and Momentum score of D.
Dave will look at Petmed’s past earnings, take a look at what is currently going on with the company, and give us his thoughts on their upcoming earnings announcement.
Furthermore, Dave will uncover some potential options trades for investors looking to make a play on Petmed Express ahead of earnings.
Petmed Express in Focus
Petmed Express is America's largest pet pharmacy, delivering prescription and non-prescription pet medications and health and nutritional supplements for dogs and cats at competitive prices direct to the consumer through its 1-800-PetMeds toll free number and on the Internet.
Petmed Express is expected to report earnings at $0.29 per share according to the Zacks Consensus Estimate. Last quarter they beat earnings expectations by 12.50%. They reported earnings at $0.45per share, beating their estimate of $0.40. They have an average earnings surprise of 10.78% over the last 4 quarters.
PetMed Express, Inc. Price, Consensus and EPS Surprise
How should investors play Petmed Express ahead of their earnings report? For insights on the best options trades, then tune in at 1:00pm CST today to see David’s thoughts.
Today's Stocks from Zacks' Hottest Strategies
It's hard to believe, even for us at Zacks. But while the market gained +18.8% from 2016 - Q1 2017, our top stock-picking screens have returned +157.0%, +128.0%, +97.8%, +94.7%, and +90.2% respectively.
And this outperformance has not just been a recent phenomenon. Over the years it has been remarkably consistent. From 2000 - Q1 2017, the composite yearly average gain for these strategies has beaten the market more than 11X over. Maybe even more remarkable is the fact that we're willing to share their latest stocks with you without cost or obligation.
Image: Bigstock
Bartosiak: Trading Petmed Express's (PETS) Earnings with Options
On Monday, October 23rd, Petmed Express (PETS - Free Report) will release its second quarter earnings before the bell. The company is a Zacks Rank 1 (Strong Buy), and have a Value, Growth, and Momentum score of D.
Dave will look at Petmed’s past earnings, take a look at what is currently going on with the company, and give us his thoughts on their upcoming earnings announcement.
Furthermore, Dave will uncover some potential options trades for investors looking to make a play on Petmed Express ahead of earnings.
Petmed Express in Focus
Petmed Express is America's largest pet pharmacy, delivering prescription and non-prescription pet medications and health and nutritional supplements for dogs and cats at competitive prices direct to the consumer through its 1-800-PetMeds toll free number and on the Internet.
Petmed Express is expected to report earnings at $0.29 per share according to the Zacks Consensus Estimate. Last quarter they beat earnings expectations by 12.50%. They reported earnings at $0.45per share, beating their estimate of $0.40. They have an average earnings surprise of 10.78% over the last 4 quarters.
PetMed Express, Inc. Price, Consensus and EPS Surprise
PetMed Express, Inc. Price, Consensus and EPS Surprise | PetMed Express, Inc. Quote
Bottom Line
How should investors play Petmed Express ahead of their earnings report? For insights on the best options trades, then tune in at 1:00pm CST today to see David’s thoughts.
Today's Stocks from Zacks' Hottest Strategies
It's hard to believe, even for us at Zacks. But while the market gained +18.8% from 2016 - Q1 2017, our top stock-picking screens have returned +157.0%, +128.0%, +97.8%, +94.7%, and +90.2% respectively.
And this outperformance has not just been a recent phenomenon. Over the years it has been remarkably consistent. From 2000 - Q1 2017, the composite yearly average gain for these strategies has beaten the market more than 11X over. Maybe even more remarkable is the fact that we're willing to share their latest stocks with you without cost or obligation.
See Them Free>>